Location History:
- Kanagawa, JP (2017)
- Kawasaki, JP (2016 - 2023)
Company Filing History:
Years Active: 2016-2023
Title: Shinya Taniguchi: A Pioneer in Alkylamine Derivatives
Introduction
Shinya Taniguchi is an esteemed inventor based in Kanagawa, Japan, recognized for his contributions to the field of pharmaceuticals and biotechnology. With a portfolio comprising three patents, Taniguchi has made significant advancements in the development of alkylamine derivatives, highlighting his innovative approach in creating compounds with potential therapeutic applications.
Latest Patents
Taniguchi's latest patents focus on alkylamine derivatives that exhibit remarkable effects as CaSR agonists. These compositions, which include a compound represented by General Formula (I), play a crucial role in developing pharmaceutical agents. They not only provide a potential prophylactic or therapeutic method for diseases that can be ameliorated through CaSR activation but also enhance seasonings and serve as agents for imparting kokumi, demonstrating a versatile application in both health and culinary fields.
Career Highlights
Throughout his career, Shinya Taniguchi has been associated with renowned companies such as Ea Pharma Co., Ltd. and Ajinomoto Co., Ltd. His work at these institutions reflects his dedication to advancing pharmaceutical sciences and his commitment to research and innovation.
Collaborations
Taniguchi has collaborated with notable professionals, including Masayuki Sugiki and Toru Okamatsu. These collaborations have enriched his research endeavors, enabling him to leverage diverse expertise to enhance the impact of his inventions.
Conclusion
Shinya Taniguchi's contributions to the field of alkylamine derivatives exemplify the spirit of innovation. His work not only advances pharmaceutical sciences but also offers insights into the integration of health benefits with culinary applications. As he continues to develop groundbreaking solutions, Taniguchi remains a significant figure in the landscape of modern inventions.